Pacira BioSciences Welcomes Shawn Cross as New CFO
Pacira BioSciences Welcomes New Chief Financial Officer
Pacira BioSciences, Inc. (NASDAQ: PCRX), a pioneer in innovative, non-opioid pain therapies, has recently appointed Shawn Cross as its Chief Financial Officer. This pivotal role will see Mr. Cross overseeing all financial operations as the company focuses on growth and value creation.
Leadership Vision and Commitment to Innovation
The CEO of Pacira, Frank D. Lee, expressed his excitement about Mr. Cross joining the leadership team. "We are delighted to welcome Shawn and look forward to his guidance in investing in long-term growth," he stated. Mr. Cross's experience in finance and his alignment with the company's mission to transform patient lives will be invaluable.
A Background in Biotechnology and Investment
With over 25 years of experience in the biotechnology sector, Mr. Cross has a distinguished career that includes roles as a board member and investment banker. Before joining Pacira, he held significant positions at Applied Molecular Transport, Inc. (AMT), where he was instrumental in the company's growth and eventual merger with Cyclo Therapeutics, Inc. (NASDAQ: CYTH).
Strategic Financial Growth and Inducement Awards
To support Mr. Cross’s role at Pacira, the Compensation Committee of the Board approved inducement awards contingent upon his appointment. These awards include a non-qualified stock option for purchasing shares of the company's common stock, along with a restricted stock unit award, both designed to enhance Mr. Cross's commitment and contributions to the company.
Pacira's Commitment to Non-Opioid Solutions
Pacira is dedicated to transforming the treatment landscape for pain management. Their suite of commercial-stage products includes EXPAREL®, ZILRETTA®, and ioveraº®, which represent innovative, non-opioid alternatives for managing pain. The company is also advancing PCRX-201, a novel gene therapy aimed at treating widespread conditions such as osteoarthritis.
Educational and Professional Foundation
Mr. Cross's educational background includes a B.S. in Kinesiology from the University of California, Los Angeles, and an M.B.A. from Columbia Business School. This robust academic foundation complements his extensive hands-on experience in the biopharmaceutical landscape.
Frequently Asked Questions
What is the new role of Shawn Cross at Pacira BioSciences?
Shawn Cross has been appointed as the Chief Financial Officer, overseeing all financial operations.
What experience does Shawn Cross bring to his new position?
Mr. Cross has over 25 years of experience as a biotechnology executive and investment banker, enhancing his capability to lead financial strategies at Pacira.
What are Pacira's primary products?
Pacira's significant products include EXPAREL®, ZILRETTA®, and ioveraº®, which provide innovative non-opioid pain management solutions.
How does Pacira support its new CFO?
To incentivize Mr. Cross's contributions, the Board approved inducement awards, including stock options and restricted stock units.
What is the mission of Pacira BioSciences?
Pacira BioSciences aims to transform patient care through innovative, non-opioid pain therapies that improve health outcomes.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Vicor's Earnings Forecast: Anticipations and Market Trends Ahead
- Exploring Enova International's Upcoming Earnings Forecast
- TruBridge Welcomes Amy O'Keefe to Board of Directors Team
- BHP Faces $47 Billion Lawsuit Over Mariana Dam Disaster
- Embassy Bank Named Best in Readers' Choice with Market Growth
- Jerome Dahan Unveils New Denim Brand, The Seven Continents
- Mexico's Inflation Trends: Key Insights for October Forecasts
- Key Insights into Texas Instruments and Competitors' Earnings
- Market Update: Earnings Season Looms as Stocks Fluctuate
- Hi-View Resources Pursues New Growth Through Private Placement
Recent Articles
- Stingray Launches Innovative Video Channels for BMW Drivers
- Transformative AI Credit Underwriting at Sidney Federal Credit Union
- Ekso Bionics Prepares for Q3 2024 Financial Results Release
- o9's Groundbreaking Catena-X Certification Revolutionizes Auto Data
- Windtree Therapeutics to Showcase Innovations at a Major Event
- Protara Therapeutics Advances IV Choline Chloride for Patients
- Reynolds and Reynolds Deepens Payments Partnership with Worldpay
- Immunohistochemistry Market Expected to Reach USD 5.5 Billion
- Cumulus Media Sets Date for Q3 2024 Results Conference Call
- Kantata Honors Innovative Leaders with 2024 Catalyst Awards
- Revolutionizing Metal Extraction with Bio-Leaching at Ferguson Lake
- Mainz Biomed's 2024 Financial Performance and Growth Strategy
- NCR Atleos Partners with Tompkins to Elevate ATM Services
- Leidos Secures Major Contract for Army Network Modernization
- Transforming Wealth Management: Vise and NewEdge Partnership
- IBM's Innovative Granite 3.0: Redefining AI for Enterprises
- Cumulus Media Plans Key Conference Call for Q3 Insights
- Hazeltree Advances zConnect for Enhanced Bank Connectivity
- Discover the High-Performance Features of PIC64HX Microprocessors
- Key Financial Insights and Future Plans for Mainz Biomed
- Exciting Anticipation for SAAS NORTH 9th Annual Conference
- Ladybug Resource Group: A Nutraceutical Revolution Ahead
- Daré Bioscience Secures $15 Million Investment for Innovation
- Dynex Capital: Insights on Q3 2024 Financial Results
- Daré Bioscience Engages Lincoln Park for $15 Million Investment
- HemoSonics Secures NIH Grant to Enhance Maternal Health Solutions
- Timex Celebrates 170 Years of Innovation with Special Watch
- Bitcoin's Upward Momentum: A Promising Future Ahead
- Discover Halia Therapeutics' Innovations at Upcoming Event
- Orgenesis Launches Trading on OTCQX Following Nasdaq Delisting
- Velocity Capital Management Welcomes Texas PSF as Partner
- Understanding California's Squatter Laws and Their Impact
- CRH Ventures Launches Accelerator for Sustainable Building Startups
- Tecsys Introduces Cutting-Edge Solutions to Boost Supply Chains
- Empowering Parents for Safe Teen Driving: Essential Tips
- ECI Group Secures Major Investment for Strategic Expansion
- Dynex Capital, Inc. Announces Dividend for Shareholders
- Thompson Thrift Celebrates New Apartment Community Opening
- Driving Safety Insights: How Apps Are Supporting Teens
- Leidos Secures Major Contract for Army's Network Modernization
- LoanCare's Innovative Digital Recapture Fuels Growth for Lenders
- Sesame Bakery: A New Culinary Delight in North Miami
- Arthur D. Little Welcomes Nine New Leaders to Global Team
- Hugoton Royalty Trust Updates Its October Cash Distribution Plan
- Celebrate the Re-Opening of Options Medical Weight Loss Clinic
- Smartkem Showcases Innovative Display Technology at TechBlick
- Thompson Thrift Unveils Luxury Living at The Garrison Community
- Vale and BHP Face Multi-Billion Dollar Dam Collapse Fallout
- Whirlpool Introduces Innovative Range to Simplify Family Meals
- ZERO Prostate Cancer Welcomes Jefferson Parker as COO